Study guide
19.2 AIA Trial Discovery, Motions, Hearing & Final Decision
USPTO Registration Examination Patent Bar
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview, Registration & MPEP Structure
1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies
2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)
2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines
3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)
3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards
4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)
4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits
5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))
5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status
6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))
6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims
7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)
7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments
8 Chapter 8: Duty of Disclosure & Information Disclosure Statements
8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance
9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)
9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice
10 Chapter 10: Continuing Applications & Copendency
10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation
11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)
11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA
12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)
12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)
13 Chapter 13: Patent Term, Maintenance Fees & Ownership
13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156
14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)
14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371
15 Chapter 15: Special Patent Categories & Professional Conduct
15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips
16 Chapter 16: Security, Access, Representation & Filing Mechanics
16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures
17 Chapter 17: Restriction, Publication, Allowance & Office Authority
17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority
18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway
18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway
19 Chapter 19: AIA Trial Practice Under the Consolidated Guide
19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision
19.2 AIA Trial Discovery, Motions, Hearing & Final Decision
Key Takeaways Explain This Topic AI
A scheduling order controls the trial; parties must seek authorization for most motions, and replies and sur-replies must respond to the preceding paper rather than introduce a new case.
Routine discovery is limited, with additional discovery requiring interests of justice in IPR and good cause in PGR.
The record is presumptively public; confidential information requires a motion to seal and an appropriate protective order, with narrowly tailored redactions.
A final written decision triggers statutory appeal and estoppel consequences, while settlement before decision requires a written agreement filed with the Board.
Last updated: August 2026
- 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision
- Scheduling and the trial record
Institution starts a compressed adjudicatory schedule. The Board issues a scheduling order setting due dates for the patent-owner response and motion to amend, petitioner reply and opposition, patent-owner sur-reply and reply on amendment, motions to exclude, observations or authorized papers, and oral hearing. The Board ordinarily issues a final written decision within one year after institution , extendable by up to six months for good cause.
The parties must confer early about claim construction, discovery, protective orders, motions, and hearing needs. A party seeking relief generally requests a conference call and authorization before filing a motion. Filing an unauthorized motion can result in expungement rather than a merits decision.
Replies must respond to arguments in the preceding paper. A petitioner cannot save an essential claim mapping or new prior-art theory for reply. A patent-owner sur-reply may respond to the reply but may not add an unrelated patentability case. The Board considers the substance and fairness of the presentation, not merely its caption.
Discovery
Routine discovery includes cited exhibits, relevant information inconsistent with a position advanced by a party, and cross-examination of affidavit testimony. A declarant is ordinarily made available for deposition, and redirect remains within the scope of cross-examination.
Additional discovery is deliberately narrower than federal civil discovery. In IPR, the requesting party must show that additional discovery is in the interests of justice ; the Garmin factors consider whether more than a possibility or allegation exists, whether litigation positions are sought, whether the information can be generated by other means, whether instructions are understandable, and whether the request is overly burdensome. In PGR, the statutory standard is good cause . The different words are testable.
Parties must not use discovery to harass, drive disproportionate expense, or circumvent page limits. Discovery disputes should be raised promptly through the Board’s conference procedure.
Motions to amend
A patent owner ordinarily may file one motion to cancel challenged claims or propose a reasonable number of substitute claims. A substitute claim must respond to a ground of unpatentability involved in the trial, may not enlarge claim scope, and may not introduce new matter. The patent owner bears the burden of production to show written-description support in the original disclosure and any earlier application relied upon.
The petitioner may oppose with prior art and other arguments, and the Board evaluates the complete record. The ultimate burden of persuasion on patentability does not simply shift to the patent owner, but the motion fails if required support and responsive narrowing are not shown. The USPTO’s motion-to-amend pilot procedures may offer preliminary guidance or a revised motion when applicable; the Consolidated Guide’s core limits still control.
Evidence, sealing, and protective orders
AIA trial records are presumptively public. A party seeking to protect confidential business information files a motion to seal and shows good cause . The proposed redactions should be narrowly tailored, and the parties may use the Board’s default protective order or propose a modified order with justification.
A protective-order designation does not automatically seal a paper. Conversely, filing sensitive information without a timely sealing motion can expose it. The Board balances genuine confidentiality against the public interest in understanding the basis of its decisions, especially for evidence relied upon in a final written decision.
Objections to evidence must be timely, allowing the offering party an opportunity to serve supplemental evidence. A motion to exclude preserves and presents an evidentiary objection; it cannot serve as a late motion for summary judgment or a new merits brief.
Oral hearing and decision
A party desiring oral argument requests a hearing by the scheduling-order deadline. Demonstratives must accurately reflect record evidence and are exchanged in advance; they are argument aids, not new evidence. The panel may question counsel and may limit argument to issues preserved in the papers.
The final written decision addresses the patentability of every challenged claim in the instituted trial and any substitute claims properly before the Board. A dissatisfied party may request rehearing under the demanding abuse-of-discretion/overlooked-matter framework and may appeal as authorized to the Federal Circuit.
After a final written decision, statutory estoppel applies to the petitioner, real party in interest, and privy for claims and grounds that were raised or reasonably could have been raised, in the forums and manner prescribed by §§ 315(e) or 325(e). Estoppel is a consequence of final decision, not merely petition filing.
Settlement and sanctions
The parties may settle, but they must put the agreement in writing and file a true copy with the Board. On request, it can be treated as business confidential and kept separate from the patent file under the statute. The Board may terminate as to a party, yet it may continue to a final decision—especially when the case is advanced—rather than permit private agreement to control the agency’s public responsibilities.
The Board can impose sanctions for abuse of process, discovery misconduct, violating an order, misleading filings, or other improper conduct. Remedies range from fees and adverse evidentiary consequences to judgment.
Trial sequence
- Phase Typical action
- Institution Scheduling order; mandatory notices and conference
- Patent-owner case Response and any authorized motion to amend
- Petitioner case Reply and opposition; responsive evidence
- Patent-owner close Sur-reply and amendment reply
- Evidentiary close Motions to exclude; authorized observations
- Hearing Argument on the existing record
- Resolution Final written decision, rehearing/appeal, or approved termination
The Board’s process is front-loaded. Each party must present its core case in its opening paper and use later papers responsively.